EMA finds rare spinal condition, AZ link

By Mrinalika Roy
Updated January 14 2022 - 7:01pm, first published 6:59pm
An EMA panel says a causal relationship between AstraZeneca and transverse myelitis is possible.

A safety panel of the European drug regulator has recommended adding a rare spinal inflammation called transverse myelitis as a side effect of AstraZeneca's COVID-19 vaccine.

Advertisement

Ad